Tonix Pharmaceuticals stock halted ahead of FDA approval news
TEL AVIV - Wix.com Ltd. (NASDAQ:WIX), currently trading at $122.85, announced Monday that its Board of Directors has authorized a $200 million increase to its securities repurchase program, potentially bringing the total repurchase authorization to $500 million. According to InvestingPro data, the company has demonstrated strong financial health with $551.25 million in levered free cash flow over the last twelve months.
The web development platform provider has already utilized $100 million of its previously authorized $400 million program. Since the beginning of 2025, the company has repurchased $300 million of its ordinary shares. This aligns with one of InvestingPro’s key observations that management has been aggressively buying back shares, while maintaining a moderate debt level with a total debt-to-capital ratio of 13%.
The expanded program allows Wix to repurchase its ordinary shares and/or convertible notes through various methods including open market purchases and privately negotiated transactions, in accordance with U.S. securities laws and regulations.
Implementation of the additional $200 million repurchase authorization is subject to Israeli law requirements, including a 30-day period for creditors to object to the distribution. The company noted that the timing, number and value of securities repurchased will depend on factors including market price, general economic conditions, capital availability, and the company’s financial results.
The repurchase program does not obligate Wix to acquire any specific amount of securities and may be suspended or discontinued at any time at the company’s discretion, according to the press release statement.
Wix, founded in 2006, provides a platform for creating and managing digital presence, serving various customer segments including self-creators, agencies, and enterprises. The company has maintained strong growth with revenue increasing by 13% year-over-year to $1.87 billion. For deeper insights into Wix’s financial health and growth prospects, investors can access comprehensive analysis through InvestingPro’s detailed research reports, which cover over 1,400 US stocks with expert analysis and actionable intelligence.
In other recent news, Wix.com reported its second-quarter results, showing revenue and free cash flow surpassing previous estimates by 1% and 4%, respectively, with bookings growth of 11% year-over-year. Scotiabank raised its price target for Wix.com to $255, highlighting the company’s shift towards monetization strategies, including longer-duration subscriptions and AI-led upsell initiatives. Meanwhile, Cantor Fitzgerald lowered its price target to $160, citing growth concerns despite the positive financial results. UBS also adjusted its price target downward to $200, noting margin concerns but maintaining a Buy rating due to strong cohort performance. Similarly, Citizens JMP reduced its price target to $160, influenced by Wix’s investments in Base44. Benchmark reaffirmed its Buy rating and $230 price target, emphasizing the company’s strong bookings and an increase in gross payment volume, particularly in the U.S. market. These developments reflect a mixed outlook from analysts, with attention on Wix.com’s evolving business strategies and financial performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.